NCPW 2025: Fighting against Deceptive Marketing
If you’ve been misled by an ad, regulators want to hear from you. We do too.
GOLO’s Release Supplement
Case Name (Date)
Bubak et al v. GOLO, LLC
21-cv-492, E.D. Cal.
(March 2021)
Product/Service
GOLO’s Release Supplement
Allegations
Implying that the supplement mitigates and prevents diabetes, heart disease, and Alzheimer’s disease by claiming that it is “the Natural Solution to Insulin Resistance”
Misleadingly marketing the supplement as “Clinically Proven” when the company relies on pilot studies that it paid for and that have not been peer reviewed or published in legitimate scientific publications
Status
Pending
The Latest
Xfinity Home Internet and Mobile Promotion
It’s easier to rack up hidden fees than it is to cancel.
AARP Membership
The only thing more “ridiculous” than the touted benefits is the cancellation process.
Should Movie Theaters Be Required to Advertise Actual Start Times?
Under a proposed bill, theaters could be fined for making moviegoers guess.
1st Phorm’s ‘110% Money-Back Guarantee’
Money-back guarantee comes up woefully short of advertised percentage.